Clinical Features and Outcome of Inflammatory Breast Cancer in Moroccan Population: Experience of Oncology Department of National Institute of Rabat

Hamouda Boussen,Hatem Bouzaiene,Jamel Ben Hassouna,Tarek Dhiab,Fathi Khomsi,Farouk Benna,Amor Gamoudi,Nejib Mourali,Monia Hechiche,Khaled Rahal,Paul Levine (2010). Inflammatory breast cancer in Tunisia.
N Mourali,L Muenz,F Tabbane,S Belhassen,J Bahi (1980). Epidemiologic features of rapidly progressing breast cancer in Tunisia.
Shine Chang,Sheryl Parker,Tuan Pham,Aman Buzdar,Stephen Hursting (1998). Inflammatory breast carcinoma incidence and survival.
K Hance,W Anderson,S Devesa,H Young,P Levine (2005). Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute.
James Lawson,Wendy Glenn,Brian Salmons,Yulan Ye,Benjamin Heng,Patrick Moody,Harpreet Johal,William Rawlinson,Warick Delprado,Louise Lutze-Mann,Noel Whitaker (2010). Mouse Mammary Tumor Virus–like Sequences in Human Breast Cancer.
S Singletary,Massimo Cristofanilli (2008). Defining the Clinical Diagnosis of Inflammatory Breast Cancer.
William Anderson,Catherine Schairer,Bingshu Chen,Kenneth Hance,Paul Levine (2005). Epidemiology of inflammatory breast cancer.
S Dawood,S Merajver,P Viens,P Vermeulen,S Swain,T Buchholz,L Dirix,P Levine,A Lucci,S Krishnamurthy,F Robertson,W Woodward,W Yang,N Ueno,M Cristofanilli (2011). International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment.
Angelo Paradiso,Stefania Tommasi,Mario Brandi,Francesco Marzullo,Gianni Simone,Vito Lorusso,Anita Mangia,Mario De Lena (1989). Cell kinetics and hormonal receptor status in inflammatory breast carcinoma. Comparison with locally advanced disease.
W Anderson,K Chu,S Chang (2003). Inflammatory breast carcinoma and non-inflammatory locally advanced breast carcinoma: distinct clinicopathologic entities?.
A Benhammida,I Labidi,K Mrad,E Charafe-Jauffret,S Arab (2008). Markers of subtypes in inflammatory breast cancer studied by immunohistochemistry.
N Chaher,H Arias-Pulido,N Terki,C Qualls,K Bouzid,C Verschraegen (2012). Molecular and epidemiological characteristics of inflammatory breast cancer in Algerian patients Breast.
M Guerin,M Gabillot,Mc Mathieu,M Travagli,N Spielmann,Andrieu (1989). Structure and expression of c-erbB-2 and EGF receptor genes in inflammatory and non-inflammatory breast cancer: prognostic significance.
Ana Gonzalez-Angulo,Nour Sneige,Aman Buzdar,Vicente Valero,Shu-Wan Kau,Kristine Broglio,Yuko Yamamura,Gabriel Hortobagyi,Massimo Cristofanilli (2004). p53 Expression as a Prognostic Marker in Inflammatory Breast Cancer.
C Kleer,K Van Golen,T Braun,S Merajver (2001). Persistent E-Cadherin Expression in Inflammatory Breast.
C Colpaert,P Vermeulen,I Benoy,A Soubry,F Van Roy,P Van Beest,G Goovaerts,L Dirix,P Van Dam,S Fox,A Harris,E Van Marck (2003). Inflammatory breast cancer shows angiogenesis with high endothelial proliferation rate and strong E-cadherin expression.
L Kenneth,Seena Van Golen,Davies,Fen Zhi,Yunfang Wu,Corazon Wang,Bucana (1999). Holly Root, : A novel putative low-affinity insulin-like growth factor-binding protein, LIBC (lost in inflammatory Breast cancer), and Rhoc GTPase correlate with the inflammatory breast cancer phenotype.
H Yamauchi,W Woodward,V Valero,R Alvarez,A Lucci,T Buchholz (2012). Inflammatory Breast Cancer: What We Know and What We Need to Learn.
T Naoto,Aman Ueno,Sonja Buzdar,Frederick Singletary,Marsha Ames,Mcneese (1997). Combined-modality treatment of inflammatory breast carcinoma: twenty years of experience at M. D. Anderson Cancer Center.
Massimo Cristofanilli,Ana Gonzalez-Angulo,Aman Buzdar,Shu-Wan Kau,Debbie Frye,Gabriel Hortobagyi (2004). Paclitaxel Improves the Prognosis in Estrogen Receptor—Negative Inflammatory Breast Cancer: The M. D. Anderson Cancer Center Experience.
Luca Gianni,Wolfgang Eiermann,Vladimir Semiglazov,Alexey Manikhas,Ana Lluch,Sergey Tjulandin,Milvia Zambetti,Federico Vazquez,Mikhail Byakhow,Mikhail Lichinitser,Miguel Climent,Eva Ciruelos,Belén Ojeda,Mauro Mansutti,Alla Bozhok,Roberta Baronio,Andrea Feyereislova,Claire Barton,Pinuccia Valagussa,Jose Baselga (2010). Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort.
B Chevallier,B Asselain,A Kunlin,C Veyret,P Bastit,Y Graic (1987). Inflammatory Breast Cancer Determination of Prognostic Factors by Univariate and Multivariate Analysis.
I Faneyte,J Schrama,J Peterse,P Remijnse,S Rodenhuis,M Van De Vijver (2003). Breast cancer response to neoadjuvant chemotherapy: predictive markers and relation with outcome.
E Bélembaogo,V Feillel,P Chollet,H Curé,P Verrelle,F Kwiatkowski,J Achard,G Le Bouëdec,J Chassagne,Y Bignon (1992). Neoadjuvant chemotherapy in 126 operable breast cancers☆.
H Kuerer,L Newman,T Smith,F Ames,K Hunt,K Dhingra (1999). Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicinebased neoadjuvant chemotherapy.
Fredika Robertson,Melissa Bondy,Wei Yang,Hideko Yamauchi,Shannon Wiggins,Samira Kamrudin,Savitri Krishnamurthy,Huong Le-Petross,Luc Bidaut,Audrey Player,Sanford Barsky,Wendy Woodward,Thomas Buchholz,Anthony Lucci,Naoto Ueno,Massimo Cristofanilli (2010). Inflammatory Breast Cancer: The Disease, the Biology, the Treatment.
Cg,P Vermeulen,L Dirix,Van Marck,E (2003). Microvessel density, expression of oestrogen receptor alpha, MIB-1, p53, and c-erbB-2 in inflammatory breast Cancer.
J Pierga,T Petit,T Delozier,J Ferrero,M Campone,J Gligorov (2012). Neoadjuvant bevacizumab, trastuzumab, and chemotherapy for primary inflammatory HER2-positive breast cancer (BEVERLY-2): an open-label, single-arm phase 2 study.
S Rabiya,Tuma (2012). ALK gene amplified in most inflammatory breast cancers.

Download References

Funding

No external funding was declared for this work.

Conflict of Interest

The authors declare no conflict of interest.

Ethical Approval

No ethics committee approval was required for this article type.

Data Availability

Not applicable for this article.

How to Cite This Article

Imane Ouziane. 2015. \u201cClinical Features and Outcome of Inflammatory Breast Cancer in Moroccan Population: Experience of Oncology Department of National Institute of Rabat\u201d. Global Journal of Medical Research - E: Gynecology & Obstetrics GJMR-E Volume 15 (GJMR Volume 15 Issue E2).

More Citation Formats

Select Citation Style:

Download Citation

GJMR Volume 15 Issue E2

Explore Journals Explore Volume Read This Issue

Journal Specifications

Crossref Journal DOI 10.17406/gjmra

Print ISSN 0975-5888

e-ISSN 2249-4618

Keywords

Not Found

Classification

GJMR-E Classification NLMC Code: WP 840

Submission ReceivedDecember 12, 2014
Peer Review Double Blind
Handling Editor
Accepted January 4, 2015
Published January 15, 2015

Version of record

v1.2

Issue date

September 12, 2015

Language

Experiance in AR

Explore published articles in an immersive Augmented Reality environment. Our platform converts research papers into interactive 3D books, allowing readers to view and interact with content using AR and VR compatible devices.

View in VR

Read in 3D

Your published article is automatically converted into a realistic 3D book. Flip through pages and read research papers in a more engaging and interactive format.

View in 3D

Article Matrices

Total Score: 130

Country: Morocco

Subject: Global Journal of Medical Research - E: Gynecology & Obstetrics

Authors: Ouziane I MD, Bensouda Y MD, HMarabti MD, Elomrani F MD,Elismaili N MD,Laanaz S MD , Elyacoubi H MD ,Berrada N MD, Boutayeb S MD, Errihani H (PhD/Dr. count: 0)

View Count (all-time): 157

Total Views (Real + Logic): 4176

Total Downloads (simulated): 2004

Publish Date: 2015 09, Sat

Monthly Totals (Real + Logic):

Month 1: 56 views
Month 2: 18 views
Month 3: 43 views
Month 4: 50 views
Month 5: 55 views
Month 6: 44 views
Month 7: 39 views
Month 8: 35 views
Month 9: 36 views
Month 10: 38 views
Month 11: 42 views
Month 12: 17 views
Month 13: 18 views
Month 14: 35 views
Month 15: 25 views
Month 16: 37 views
Month 17: 25 views
Month 18: 35 views
Month 19: 23 views
Month 20: 25 views
Month 21: 42 views
Month 22: 19 views
Month 23: 42 views
Month 24: 28 views
Month 25: 33 views
Month 26: 36 views
Month 27: 32 views
Month 28: 47 views
Month 29: 28 views
Month 30: 26 views
Month 31: 37 views
Month 32: 30 views
Month 33: 40 views
Month 34: 25 views
Month 35: 14 views
Month 36: 26 views
Month 37: 35 views
Month 38: 23 views
Month 39: 39 views
Month 40: 40 views
Month 41: 16 views
Month 42: 26 views
Month 43: 24 views
Month 44: 38 views
Month 45: 35 views
Month 46: 30 views
Month 47: 20 views
Month 48: 22 views
Month 49: 29 views
Month 50: 40 views
Month 51: 25 views
Month 52: 37 views
Month 53: 32 views
Month 54: 24 views
Month 55: 19 views
Month 56: 13 views
Month 57: 21 views
Month 58: 27 views
Month 59: 24 views
Month 60: 36 views
Month 61: 40 views
Month 62: 18 views
Month 63: 27 views
Month 64: 18 views
Month 65: 40 views
Month 66: 26 views
Month 67: 28 views
Month 68: 46 views
Month 69: 27 views
Month 70: 43 views
Month 71: 34 views
Month 72: 23 views
Month 73: 45 views
Month 74: 41 views
Month 75: 19 views
Month 76: 23 views
Month 77: 29 views
Month 78: 39 views
Month 79: 38 views
Month 80: 42 views
Month 81: 34 views
Month 82: 24 views
Month 83: 24 views
Month 84: 35 views
Month 85: 33 views
Month 86: 40 views
Month 87: 30 views
Month 88: 19 views
Month 89: 27 views
Month 90: 47 views
Month 91: 35 views
Month 92: 18 views
Month 93: 47 views
Month 94: 26 views
Month 95: 30 views
Month 96: 35 views
Month 97: 36 views
Month 98: 35 views
Month 99: 37 views
Month 100: 40 views
Month 101: 24 views
Month 102: 22 views
Month 103: 12 views
Month 104: 33 views
Month 105: 17 views
Month 106: 32 views
Month 107: 21 views
Month 108: 14 views
Month 109: 35 views
Month 110: 36 views
Month 111: 16 views
Month 112: 33 views
Month 113: 38 views
Month 114: 22 views
Month 115: 17 views
Month 116: 34 views
Month 117: 38 views
Month 118: 36 views
Month 119: 20 views
Month 120: 42 views
Month 121: 19 views
Month 122: 36 views
Month 123: 35 views
Month 124: 12 views
Month 125: 35 views
Month 126: 75 views
Month 127: 47 views
Month 128: 56 views
Month 129: 34 views

Total Views: 4176

Total Downloads: 2004

2026 Trends

Our website is actively being updated, and changes may occur frequently. Please clear your browser cache if needed. For feedback or error reporting, please email [email protected]